• About us

    With a presence amongst the top 10 global veterinary pharmaceutical laboratories, Vetoquinol is first and foremost an independent, family-owned business.Deeply committed to its values, it has always enjoyed a close relationship with its vet clients.

  • Working at Vetoquinol

      

  • Achieve More Together

    Building trustworthy relationships with all stakeholders in animal health across the globe.

Vetoquinol live

  • Q3 2019 SALES: €100.2 MILLION (UP 11.0%)

    16 Oct 2019
    The Vetoquinol Group posted sales of €100.2 million for the third quarter of 2019, up 11.0% as reported and up 9.4% at constant exchange rates compared to the same period last year. Exchange rate fluctuations and acquisitions had positive impacts of 1.6% and 4.1% respectively in Q3 2019.
  • FIRST HALF 2019 RESULTS

    25 Jul 2019
    At its meeting on July 24, 2019, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the audited first half 2019 financial statements.
  • VETOQUINOL ANNOUNCES A NEW MILESTONE IN ITS INDUSTRIAL STRATEGY

    12 Jul 2019
    Vetoquinol, a leading global animal health player, today announces a plan to reorganize its production facilities in Europe. This decision is in line with the Group’s strategy of streamlining operations in order to improve its response to customer needs, whether vets, breeders or pet owners.
  • COMBINED ORDINARY AND EXTRAORDINARY GENERAL MEETING MAY 21, 2019

    22 May 2019
    The Combined Ordinary and Extraordinary General Meeting of Vetoquinol shareholders was held on Tuesday May 21, 2019 in Lure, chaired by Etienne Frechin.
  • 24 january 2019

    2018 Annual revenues (after market)

  • 21 March 2019

    2018 Annual results (before market)

  • 17 april 2019

    2019 First quarter revenues (after market)

Veterinarians

CONTACT US
Find the nearest Vetoquinol contact point by selecting a country website
VETOQUINOL IN THE WORLD